Has Kimberly Resnick, MD received payments from drug or device companies?

Yes. Drug and device makers reported $29,023 in general payments to Kimberly Resnick, MD across 40 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kimberly Resnick, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kimberly Resnick, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kimberly Resnick, MD

Gynecologic Oncology · Cleveland, OHNPI 1821208513

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $19,500 of the $29,023 with a category attached, or 67.2%. Clovis Oncology, Inc. accounts for 80.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $23,366 and has fallen 84.6% since, to $3,592 in 2025.

$29,023in general payments, 2019–2025

Across 40 payments — averaging $725.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Clovis Oncology, Inc.$23K
Pfizer$4K
Intuitive Surgical$1K
AstraZeneca$125
Eisai Inc.$42
Genmab U.S., Inc.$41
plus $52 from 2 others

$444,784in research payments, 2019–2025

Across 18 payments — averaging $24,710 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Merck$363K
AstraZeneca$47K
Astrazeneca UK Limited$20K
Karyopharm Therapeutics Inc.$13K
E.r. Squibb & Sons, L.L.C.$2K
Pfizer$500

What the payments were for

Consulting fees$3,50012%
Speaking & faculty fees$19,50067%
Travel & lodging$4,93717%
Food & beverage$1,0864%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Clovis Oncology, Inc.	17	$23,241
Pfizer	4	$4,413
Intuitive Surgical	11	$1,108
AstraZeneca	1	$125
Eisai Inc.	2	$42
Genmab U.S., Inc.	2	$41
Merck	2	$30
Takeda Pharmaceuticals U.S.A., Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,023 in reported general payments places this provider in the 85th percentile of 62 gynecologic oncology providers in Ohio.

See all gynecologic oncology providers in Ohio →

Medicare billing

Part B allowed, 2024

$27,046

Medicare patients

Services billed

202

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	15	$341
Dexamethasone	12	$191
Letrozole	13	$185
Oxycodone Hcl	11	$121
Duloxetine Hcl	11	$111
Anastrozole	11	$107
Pantoprazole Sodium	12	$50

Paid to pharmacies, not to this prescriber.

Other gynecologic oncology in Cleveland

Amelia JerniganCleveland$85K
Peter RoseCleveland$4K
Kevin EliasCleveland$4K
Chad MichenerCleveland$3K
Mariam Al HilliCleveland$2K
Robert DebernardoCleveland$2K
Anthony RizzoCleveland$1K
Lisa Rauh-BenoitCleveland$930
Roberto VargasCleveland$482
Lindsay FergusonCleveland$467

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →